RS56255B1 - Postupak proizvodnje jedinjenja triazola - Google Patents

Postupak proizvodnje jedinjenja triazola

Info

Publication number
RS56255B1
RS56255B1 RS20170869A RSP20170869A RS56255B1 RS 56255 B1 RS56255 B1 RS 56255B1 RS 20170869 A RS20170869 A RS 20170869A RS P20170869 A RSP20170869 A RS P20170869A RS 56255 B1 RS56255 B1 RS 56255B1
Authority
RS
Serbia
Prior art keywords
triazol
formula
ethyl
methyl
compound
Prior art date
Application number
RS20170869A
Other languages
English (en)
Serbian (sr)
Inventor
Hans-Christian Militzer
Johannes Eggert
Original Assignee
Bayern Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48325714&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS56255(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayern Pharma Ag filed Critical Bayern Pharma Ag
Publication of RS56255B1 publication Critical patent/RS56255B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/041,2,3-Triazoles; Hydrogenated 1,2,3-triazoles

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
RS20170869A 2012-05-08 2013-05-06 Postupak proizvodnje jedinjenja triazola RS56255B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP12167152 2012-05-08
PCT/EP2013/059418 WO2013167552A1 (de) 2012-05-08 2013-05-06 Verfahren zur herstellung von triazol-verbindungen
EP13720943.3A EP2847183B1 (de) 2012-05-08 2013-05-06 Verfahren zur herstellung von triazol-verbindungen

Publications (1)

Publication Number Publication Date
RS56255B1 true RS56255B1 (sr) 2017-11-30

Family

ID=48325714

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20170869A RS56255B1 (sr) 2012-05-08 2013-05-06 Postupak proizvodnje jedinjenja triazola

Country Status (35)

Country Link
US (1) US10301289B2 (https=)
EP (1) EP2847183B1 (https=)
JP (1) JP6149104B2 (https=)
KR (1) KR102086389B1 (https=)
CN (1) CN104411704B (https=)
AP (1) AP2014008089A0 (https=)
AU (1) AU2013258107B2 (https=)
BR (1) BR112014027564B1 (https=)
CA (1) CA2872726C (https=)
CL (2) CL2014003003A1 (https=)
CO (1) CO7121324A2 (https=)
CR (1) CR20140514A (https=)
CU (1) CU20140128A7 (https=)
DK (1) DK2847183T3 (https=)
DO (1) DOP2014000254A (https=)
EA (1) EA027804B1 (https=)
ES (1) ES2641205T3 (https=)
HR (1) HRP20171321T1 (https=)
HU (1) HUE034430T2 (https=)
IL (1) IL235441A (https=)
LT (1) LT2847183T (https=)
MX (1) MX350519B (https=)
MY (1) MY184577A (https=)
NZ (1) NZ701661A (https=)
PE (1) PE20142453A1 (https=)
PH (1) PH12014502482A1 (https=)
PL (1) PL2847183T3 (https=)
PT (1) PT2847183T (https=)
RS (1) RS56255B1 (https=)
SG (2) SG10201609319YA (https=)
SI (1) SI2847183T1 (https=)
TN (1) TN2014000469A1 (https=)
UA (1) UA116349C2 (https=)
WO (1) WO2013167552A1 (https=)
ZA (1) ZA201408571B (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2639716B2 (ja) 1988-12-14 1997-08-13 横浜ゴム株式会社 タイヤ成形装置に於けるグリーンタイヤの搬送装置
JOP20170103A1 (ar) * 2016-05-03 2017-11-03 Bayer Pharma AG عملية لتحضير مشتقات 1-فنيل-1، 2، 4-تريازول مستبدلة بـ 5-هيدروكسي ألكيل
CN108084099B (zh) * 2017-12-20 2019-01-29 天驰药业有限公司 一种1,2,3-三氮唑化合物的合成方法
US10702525B1 (en) 2019-09-04 2020-07-07 United Arab Emirates University Pyrimidine derivatives as anti-diabetic agents
EP3888684A1 (en) 2020-03-31 2021-10-06 Bayer Animal Health GmbH Composition having improved voluntary acceptance
JP7710897B2 (ja) * 2021-06-01 2025-07-22 三菱ガス化学ネクスト株式会社 1-アルキル-5-ヒドロキシピラゾールの製造方法
CN114264752B (zh) * 2021-12-29 2023-08-15 北京金城泰尔制药有限公司 溴乙酸甲酯的检测方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK135184A (da) 1983-03-03 1984-10-10 Riker Laboratories Inc Triazol(4,3-c)- og triazol(1,5-c)pyrimidiner
US4572910A (en) * 1983-03-03 1986-02-25 Riker Laboratories, Inc. Triazolo[1,5-c]pyrimidines substituted by nitrogen-containing heterocyclic rings
US4752910A (en) 1984-10-30 1988-06-21 Prime Computer, Inc. Method and apparatus for continuous after-imaging
UY27813A1 (es) * 2002-05-31 2003-12-31 Smithkline Beecham Corp Inhibidores de la peptido-desformilasa
CL2003002353A1 (es) 2002-11-15 2005-02-04 Vertex Pharma Compuestos derivados de diaminotriazoles, inhibidores d ela proteina quinasa; composicion farmaceutica; procedimiento de preparacion; y su uso del compuesto en el tratamiento de enfermedades de desordenes alergicos, proliferacion, autoinmunes, condic
WO2005044785A1 (en) * 2003-10-30 2005-05-19 Merck & Co., Inc. Aralkyl amines as cannabinoid receptor modulators
US7745630B2 (en) 2003-12-22 2010-06-29 Justin Stephen Bryans Triazolyl piperidine arginine vasopressin receptor modulators
DE102008020113A1 (de) 2008-04-23 2009-10-29 Bayer Schering Pharma Aktiengesellschaft Substituierte Dihydropyrazolone und ihre Verwendung
EP1877399A1 (en) 2005-04-26 2008-01-16 Pfizer Limited Triazole derivatives as vasopressin antagonists
CA2608718A1 (en) 2005-05-18 2006-11-23 Pfizer Limited 1, 2, 4-triazole derivatives as vasopressin antagonists
DE102006050516A1 (de) * 2006-10-26 2008-04-30 Bayer Healthcare Ag Substituierte Dihydropyrazolone und ihre Verwendung
DE102010041236A1 (de) * 2010-09-23 2012-03-29 Osram Ag Optoelektronisches Halbleiterbauelement
DE102010044131A1 (de) * 2010-11-18 2012-05-24 Bayer Schering Pharma Aktiengesellschaft Substituiertes Natrium-1H-pyrazol-5-olat

Also Published As

Publication number Publication date
JP2015516403A (ja) 2015-06-11
EP2847183B1 (de) 2017-06-21
CO7121324A2 (es) 2014-11-20
CR20140514A (es) 2014-12-02
LT2847183T (lt) 2017-09-25
CA2872726A1 (en) 2013-11-14
KR20150018534A (ko) 2015-02-23
SG10201609319YA (en) 2016-12-29
TN2014000469A1 (en) 2016-03-30
EA027804B1 (ru) 2017-09-29
WO2013167552A1 (de) 2013-11-14
CL2014003003A1 (es) 2015-02-13
IL235441A (en) 2017-09-28
ZA201408571B (en) 2016-03-30
HK1208027A1 (en) 2016-02-19
BR112014027564A2 (https=) 2017-08-22
PL2847183T3 (pl) 2017-11-30
JP6149104B2 (ja) 2017-06-14
PE20142453A1 (es) 2015-01-17
UA116349C2 (uk) 2018-03-12
KR102086389B1 (ko) 2020-03-09
HRP20171321T1 (hr) 2017-10-20
MX350519B (es) 2017-09-08
US20150087827A1 (en) 2015-03-26
SI2847183T1 (sl) 2017-10-30
DK2847183T3 (en) 2017-10-02
NZ701661A (en) 2016-08-26
PH12014502482A1 (en) 2015-01-12
CN104411704A (zh) 2015-03-11
SG11201407043PA (en) 2014-12-30
AP2014008089A0 (en) 2014-11-30
MY184577A (en) 2021-04-06
CL2016001165A1 (es) 2016-12-02
HUE034430T2 (en) 2018-02-28
AU2013258107A1 (en) 2014-11-27
MX2014013448A (es) 2014-12-08
ES2641205T3 (es) 2017-11-08
US10301289B2 (en) 2019-05-28
PT2847183T (pt) 2017-10-02
AU2013258107B2 (en) 2017-06-22
DOP2014000254A (es) 2016-01-31
EP2847183A1 (de) 2015-03-18
BR112014027564B1 (pt) 2022-05-03
CN104411704B (zh) 2017-12-22
EA201492032A1 (ru) 2015-04-30
CA2872726C (en) 2020-07-07
CU20140128A7 (es) 2015-03-30

Similar Documents

Publication Publication Date Title
RS56255B1 (sr) Postupak proizvodnje jedinjenja triazola
CA2781799C (en) Method for producing methyl-{4,6-diamino-2-[1-(2-fluorobenzyl)-1h-pyrazolo[3,4-b]pyridino-3-yl]pyrimidino-5-yl}methyl carbamate and its purification for use thereof as pharmaceutical substance
CA3006946C (en) Method for producing 2-[4-(4-chlorophenoxy)-2-(trifluoromethyl)phenyl]-1-(1,2,4-triazol-1-yl)propan-2-ol
KR20170102887A (ko) 브루톤 티로신 키나제 저해제의 합성
RS57569B1 (sr) Postupci za pripremanje agensa koji uzrokuje apoptozu
KR20180101342A (ko) 4-((6-(2-(2,4-디플루오로페닐)-1,1-디플루오로-2-히드록시-3-(1h-1,2,4-트리아졸-1-일)프로필)피리딘-3-일)옥시)벤조니트릴 및 제조방법
WO2014093583A2 (en) Synthetic methods for preparing 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide mono hydrochloride, other salt forms of this compound and intermediates thereof
RU2688665C2 (ru) Новый способ получения производных триазина, пиримидина и пиридина
CN110612291B (zh) 2-([1,2,3]三唑-2-基)-苯甲酸衍生物的制备
BG65699B1 (bg) Метод за синтез на познато тетразолово производно
Shuangxia et al. An efficient and green synthetic route to losartan
EP3153498B1 (en) N-substituted phenyl glycine preparation method
SK288040B6 (sk) Method for producing beta-hydroxyalkylamide compounds
CN1944422B (zh) 二氧杂环己烷二醇的制备方法
AU2017387801B2 (en) Methods for the preparation of 6-aminoisoquinoline
BR112012029363B1 (pt) Processo para preparar 1-alquil-3-difluorometil-5 -hidroxipirazóis
JP3160321B2 (ja) アミノ酸アミノアルキルエステルの製造法
HK1208027B (en) Method for the preparation of triazole compounds
WO2025256636A1 (zh) 含氮化合物及其制备方法
WO2020234379A1 (en) Processes and intermediates for preparing a btk inhibitor
CN103209961A (zh) 用于制备2,3-二氨基丙酸衍生物的对映异构体形式的方法
PL216764B1 (pl) Nowe sposoby wytwarzania estrów kwasu 5-amino-3-metylo-4-izoksazolokarboksylowego